Jun 6, 2024 | H&P News, M&A
BÜHLMANN Laboratories AG from Schönenbuch announces the completion of the acquisition by KLAR Partners Limited. Thanks to the acquisition, the company’s future is in safe hands. The strong global market positions of the BÜHLMANN Group will be further expanded. Since...
Apr 30, 2024 | CFO-Services, H&P News, M&A
It was a wonderful opportunity to meet and exchange ideas with so many inspiring people dedicated to life sciences and biotech at the Swiss Biotech Day in Basel. Take a look at the video interview to hear more about an aspect of our innovative solutions and...
Apr 4, 2024 | H&P News, M&A
Within the DACH region, the number of transactions in the Health Care industry declined by 24% between 2022 and 2023. Switzerland, however, keeps developing positively and remains on a constant level when it comes to the number of transactions. In the following...
Feb 26, 2024 | CFO-Services, Corporate Finance, H&P News, M&A
Switzerland’s rise as the hub for life sciences startups is intrinsically linked to its growing ecosystem of biotech, medtech, and nanotech companies. This thriving ecosystem benefits from substantial investment in research and development, with the Swiss biotech...
Dec 12, 2023 | H&P News, M&A
Predictive Layer, the Swiss provider of forecasting solutions in the energy and commodity trading sector, was sold to TotalEnergies. Hoffmann & Partner acted as the exclusive financial advisor to the sellers. TotalEnergies will improve the performance of its...
Nov 30, 2023 | H&P News, M&A
We advised Stille, a listed Swedish medtech company, in the acquisition of Fehling Instruments based in Germany in a joint mandate with our AICA network partner Evli Corporate Finance. Through the acquisition, Stille significantly broadens its product offering of...
